Showing 1821-1840 of 7110 for: Cochrane Systematic Reviews Back
- Diuretics for preventing pre-eclampsia
Cochrane Systematic Reviews, 14-Jun-2010
Diuretics are used to reduce blood pressure and oedema in non-pregnant individuals. Formerly, they were used in pregnancy with the aim of preventing or delaying the development of pre-eclampsia. This practice became controversial when concerns were raised
- Diuretics for respiratory distress syndrome in preterm infants
Cochrane Systematic Reviews, 3-Nov-2011
Lung edema may complicate respiratory distress syndrome (RDS) in preterm infants.
- Diuretics for transient tachypnoea of the newborn
Cochrane Systematic Reviews, 20-Nov-2015
Transient tachypnoea of the newborn (TTN) results from delayed clearance of lung liquid and is a common cause of admission of full-term infants to neonatal intensive care units. The condition is particularly common after elective caesarean section. Conven
- D‐mannose for preventing and treating urinary tract infections
Cochrane Systematic Reviews, 30-Aug-2022
Urinary tract infections (UTIs) are very common, affecting more than 7 million people worldwide. Whilst many people may only experience a single episode in their lifetime and are generally responsive to standard antibiotics, a significant proportion of ad
- Doctors or mid-level providers for abortion
Cochrane Systematic Reviews, 20-Jul-2015
The World Health Organization recommends that abortion can be provided at the lowest level of the healthcare system. Training mid-level providers, such as midwives, nurses and other non-physician providers, to conduct first trimester aspiration abortions
- Domestic violence screening and intervention programmes for adults with dental or facial injury
Cochrane Systematic Reviews, 27-Oct-2015
Domestic violence exists in all communities across the world. Healthcare services have a pivotal role in the identification, assessment and response to domestic violence. As the face is a common target in assault, dentists and oral and maxillofacial surge
- Domiciliary oxygen for chronic obstructive pulmonary disease
Cochrane Systematic Reviews, 22-Jul-2008
Domiciliary oxygen therapy has become one of the major forms of treatment for hypoxaemic chronic obstructive pulmonary disease (COPD) patients.
- Domiciliary oxygen for interstitial lung disease
Cochrane Systematic Reviews, 4-Nov-2010
Retrospective survival data have suggested poor effectiveness of oxygen therapy in patients with interstitial lung disease (ILD).
- Donepezil for dementia due to Alzheimer's disease
Cochrane Systematic Reviews, 3-Nov-2008
Alzheimer's disease is the most common cause of dementia in older people. One of the aims of therapy is to inhibit the breakdown of a chemical neurotransmitter, acetylcholine, by blocking the relevant enzyme. This can be done by a group of chemicals known
- Donepezil for dementia in people with Down syndrome
Cochrane Systematic Reviews, 18-Nov-2008
Alzheimer's dementia (AD) is the most common form of dementia in people with Down Syndrome [DS]. Acetylcholine is a chemical found in the brain that has an important role in memory, attention, reason and language. Donepezil a reversible inhibitor of acety
- Donepezil for mild cognitive impairment
Cochrane Systematic Reviews, 9-Nov-2010
Problems with memory which do not meet the diagnostic criteria for dementia, usually called mild cognitive impairment (MCI), can be the first sign of an impending dementia, particularly Alzheimer's disease (AD). There is no consensus on a definition or di
- Donepezil for vascular cognitive impairment
Cochrane Systematic Reviews, 3-Nov-2008
Vascular disease is the second commonest cause of dementia after Alzheimer's disease. There are difficulties in classifying patients with this type of cognitive impairment owing to varied clinical presentation and different types of arterial disease. Ther
- Dopamine agents for hepatic encephalopathy
Cochrane Systematic Reviews, 6-Feb-2014
Patients with hepatic encephalopathy may present with extrapyramidal symptoms and changes in basal ganglia. These changes are similar to those seen in patients with Parkinson's disease. Dopamine agents (such as bromocriptine and levodopa, used for patient
- Dopamine agonist therapy in early Parkinson's disease
Cochrane Systematic Reviews, 12-Nov-2008
Dopamine agonists are being used increasingly as first line treatment for Parkinson's disease, but there remains uncertainty about their clinical and cost-effectiveness relative to levodopa.
- Dopamine agonists for the treatment of restless legs syndrome
Cochrane Systematic Reviews, 24-Mar-2011
According to clinical guidelines, dopamine agonists are the first-line treatment of restless legs syndrome (RLS).
- Dopamine for prevention of morbidity and mortality in term newborn infants with suspected perinatal asphyxia
Cochrane Systematic Reviews, 29-Oct-2008
Perinatal asphyxia remains an important condition with significant mortality and long-term morbidity. Multisystem involvement including hypotension and low cardiac output is common in infants with perinatal asphyxia. Dopamine is commonly used for infants
- Dopamine transporter imaging for the diagnosis of dementia with Lewy bodies
Cochrane Systematic Reviews, 26-Jan-2015
Dementia with Lewy bodies (DLB) is a common cause of neurodegenerative dementia of old age. Its accurate recognition can be important in clinical management and is essential for the development of disease-modifying treatments. The current clinical diagnos
- Dopamine versus dobutamine for hypotensive preterm infants
Cochrane Systematic Reviews, 14-Sep-2008
Inotropes are widely used in preterm infants to treat systemic hypotension. The most commonly used drugs are dopamine and dobutamine. These agents have different modes of action which may result in different haemodynamic effects.
- Dopamine versus no treatment to prevent renal dysfunction in indomethacin-treated preterm newborn infants
Cochrane Systematic Reviews, 10-Nov-2009
Indomethacin therapy for closure of patent ductus arteriosus (PDA) frequently causes oliguria and occasionally more serious renal dysfunction. Low dose dopamine has been suggested as a means for preventing this side effect.
- Dornase alfa for cystic fibrosis
Cochrane Systematic Reviews, 18-Mar-2021
Dornase alfa is currently used as a mucolytic to treat pulmonary disease (the major cause of morbidity and mortality) in cystic fibrosis. It reduces mucus viscosity in the lungs, promoting improved clearance of secretions. This is an update of a previousl
